EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Low-DMSO Cryopreservation and Expansion Strategies Enhance Cord Blood CD34⁺ Stem Cell Recovery and Function

Noor Farhan Shamkhi, Majeed Arsheed Sabbah, Sabah Nasser Alwachi

World Journal of Experimental Biosciences · 18.04.2026 · 16-22

DOI: 10.65329/wjeb.v14.01.04 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Experimental Biosciences, online erschienen am 18.04.2026. Verfasst von Noor Farhan Shamkhi und 2 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Umbilical cord blood (UCB) is a source of CD34+ hematopoietic stem cells (HSCs). The main challenges in handling them are the cytotoxicity of 10% dimethyl sulfoxide (DMSO) cryoprotection and insufficient cell number from a single cord blood unit. To address them, UCB-derived mononuclear cells (MNCs) were isolated by Ficoll density gradient centrifugation and cryopreserved in different formulations: 2.5% or 5% DMSO, each alone or supplemented with trehalose (25 µg/mL) or ascorbic acid (80 µg/mL). Post-thaw, viable MNC counts were assessed using trypan blue viability, and CD34+ immunocytochemistry was performed. To overcome the second challenge, MNCs were cultured for 7 days with 5%, 10%, or 25% placental extract, or for 4 days with 4 plant hormones, including kinetin, indole-3-acetic acid, naphthaleneacetic acid, and gibberellic acid at 2.5 and 5 mg/L. The MTT assay was used to evaluate the cytotoxicity. The results showed that 5% DMSO with trehalose yielded the highest post-thaw MNC count (4.70 ± 0.10 × 106 cells/mL) and viability of 54.50 ± 0.28%, whereas 5% DMSO with ascorbic acid produced the highest CD34+ retention (81.16 ± 0.60%), both significantly higher than in 2.5% DMSO formulations (P < 0.05). 5% placental extract increased cloning efficiency 5.7-fold compared with the control (P < 0.05). The hormones used depleted differentiated MNCs while preserving CD34+ content at 89-96%. These findings establish 5% DMSO with trehalose or ascorbic acid as an alternative to conventional 10% DMSO protocols, and 5% placental extract as a cost-effective HSC expansion supplement with direct translational importance for cord blood banking and transplantation medicine.

Zitieren

APA

Shamkhi, N. F., Sabbah, M. A., & Alwachi, S. N. (2026). Integrated Low-DMSO Cryopreservation and Expansion Strategies Enhance Cord Blood CD34⁺ Stem Cell Recovery and Function. World Journal of Experimental Biosciences, 16-22. https://doi.org/10.65329/wjeb.v14.01.04

Vancouver

Shamkhi NF, Sabbah MA, Alwachi SN. Integrated Low-DMSO Cryopreservation and Expansion Strategies Enhance Cord Blood CD34⁺ Stem Cell Recovery and Function. World Journal of Experimental Biosciences. 2026:16-22. doi:10.65329/wjeb.v14.01.04

BibTeX
@article{Shamkhi2026,
  author = {Shamkhi, Noor Farhan and Sabbah, Majeed Arsheed and Alwachi, Sabah Nasser},
  title = {Integrated Low-DMSO Cryopreservation and Expansion Strategies Enhance Cord Blood CD34⁺ Stem Cell Recovery and Function},
  journal = {World Journal of Experimental Biosciences},
  year = {2026},
  pages = {16--22},
  doi = {10.65329/wjeb.v14.01.04}
}
Kostenlos starten →